ZILRETTA
006-C-301
Phase 3 small_molecule active
Quick answer
ZILRETTA for Glenohumeral Osteoarthritis is a Phase 3 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Glenohumeral Osteoarthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active